Paliperidone

This classification denotes an antipsychotic agent with the molecular formula C23H27FN4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 838F01T721, chemically known as 4h-pyrido(2,1-a)pyrimidin-4-one, 6,7,8,9-tetrahydro-3-(2-(4-(6-fluro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-9-hydroxy-2-methyl- but generally known as paliperidone, which bears US NIH Compound Identifier 115237. European Medicines Agency schedules Paliperidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB23268. The term PALIPERIDONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 No. 1, 2001, List 45). World Health Organization schedules paliperidone in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule paliperidone under HS 29349990 and SITC 51579. As of Q4 2014, PALIPERIDONE remains the US FDA Preferred Term for this commodity. Paliperidone bears US NLM identifiers UMLS ID C0753678 and NCI Concept Code C66293. SMILES: FC1CC2ONC(C3CCN(CC3)CCC3C(=O)N4CCCC(O)C4NC3C)C2CC1.